Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

DNA virus-induced tumors have consistent isozyme profiles, unlike other tumor types.

The BIOMAP glossary standardizes data to improve research on atopic dermatitis and psoriasis.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

IVIg treatment improved symptoms but caused permanent dark hair loss.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Immunotherapy can help treat severe alopecia areata.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

A new image-based method improves accuracy in measuring hair loss in mice.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.